Compare HOST & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOST | ADVB |
|---|---|---|
| Founded | 2025 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.5M | 8.6M |
| IPO Year | 2023 | 2023 |
| Metric | HOST | ADVB |
|---|---|---|
| Price | $2.42 | $3.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 448.5K | 32.1K |
| Earning Date | 11-03-2026 | 10-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.00 | ★ 3431.25 |
| EPS | N/A | ★ 5.33 |
| Revenue | ★ $78,205,678.00 | $127,637.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.97 | N/A |
| P/E Ratio | ★ N/A | $0.75 |
| Revenue Growth | ★ 12.74 | N/A |
| 52 Week Low | $1.48 | $3.15 |
| 52 Week High | $8.99 | $113.80 |
| Indicator | HOST | ADVB |
|---|---|---|
| Relative Strength Index (RSI) | 21.02 | 22.98 |
| Support Level | $1.48 | N/A |
| Resistance Level | $8.27 | $5.59 |
| Average True Range (ATR) | 0.51 | 0.57 |
| MACD | 0.06 | -0.16 |
| Stochastic Oscillator | 45.12 | 11.48 |
Host Digital Infrastructure LLC is a U.S.-based infrastructure company focused on the development and operation of power-intensive data centers designed to support high-performance computing workloads, including artificial intelligence, data processing, and other compute-intensive applications. The company focuses on securing power resources and deploying computing capacity in regions across the United States.
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.